Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

NCCN incentiva o aperfeiçoamento dos tratamentos de câncer em todo o mundo no Dia Mundial do Câncer
  • USA - slovenčina
  • USA - Pусский
  • USA - English
  • USA - Français
  • USA - español
  • USA - Deutsch
  • USA - Polski
  • Latin America - español
  • USA - čeština

A aliança sem fins lucrativos que apoia as diretrizes de oncologia padrão ouro compartilha histórias de conexões pessoais com o câncer que inspiram muitas pessoas na organização.

A comunidade global de oncologia analisa o impacto da COVID-19 no tratamento do câncer no ano passado.

NCCN Logo (C)NCCN(R) 2018. All rights reserved.

News provided by

National Comprehensive Cancer Network

Feb 04, 2021, 06:05 ET

Share this article

Share toX

Share this article

Share toX

PLYMOUTH MEETING, Pensilvânia, 4 de fevereiro de 2021 /PRNewswire/ -- A National Comprehensive Cancer Network®(NCCN®)— uma aliança dos principais centros de câncer nos Estados Unidos — reúne pessoas e organizações em todo o mundo na comemoração do Dia Mundial do Câncer todo dia 4 de fevereiro. O Dia Mundial do Câncer 2021 é dedicado à coragem e às conquistas dos pacientes de câncer e suas famílias, bem como de cuidadores, prestadores de cuidados de saúde, pesquisadores, defensores e outros voluntários, e convoca todos a se unirem para ajudar a salvar vidas. Os esforços do Dia Mundial do Câncer de 2021 são liderados pela União Internacional para o Controle do Câncer (Union for International Cancer Control, UICC) - da qual a NCCN é membro. O tema "I am and I Will" sintetiza o extraordinário espírito e a força da comunidade do câncer. Para 2021, os funcionários da NCCN participaram de um desafio de 21 dias para obter informações pessoais sobre o tratamento do câncer, compartilhando um olhar sobre como as vidas de diferentes membros da equipe foram diretamente afetadas pelo câncer.

"As Diretrizes da NCCN não são apenas o padrão reconhecido para orientação clínica e política no tratamento do câncer e as diretrizes de prática clínica mais completas e frequentemente atualizadas disponíveis em uma área da medicina; elas também representam como queremos que nossos entes queridos e nós mesmos sejamos tratados", explicou Robert W. Carlson, diretor executivo da NCCCN. "As diretrizes da NCCN e os recursos relacionados são organizados por painéis multidisciplinares de importantes especialistas em todos os tipos de câncer, com o apoio da nossa equipe dedicada. Nosso trabalho de ajudar os pacientes a ter uma vida melhor é mais do que um trabalho, é uma vocação. Isso não é mais evidente do que nas muitas histórias pessoais que nossa equipe apresentou para inclusão neste desafio do Dia Mundial do Câncer."

As diretrizes de prática clínica da NCCN em Oncologia (Diretrizes da NCCN®) são recursos gratuitos que ajudam a elevar os padrões de tratamento do câncer em todo o mundo. As recomendações baseadas em evidências e orientadas por consenso são destinadas a garantir que todos os pacientes recebam os serviços de prevenção, diagnóstico, tratamento e suporte que sejam mais propensos a gerar melhores resultados. As recomendações foram baixadas mais de 11,7 milhões de vezes em todo o mundo em 2020. As diretrizes da NCCN ® contemplam atualmente 79 tópicos diferentes e estão disponíveis em diversos formatos em 50 idiomas.

Nos últimos 12 meses, a NCCN também se empenhou para manter e otimizar a qualidade do tratamento de câncer durante a atual pandemia da COVID-19. Este trabalho inclui princípios de orientação para a vacinação de pessoas com câncer; uma instrução multiorganizacional sobre a importância de retomar a avaliação e tratamento seguros e recomendados de câncer; as melhores práticas para manter os pacientes e os funcionários protegidos contra infecções, além de informações sobre o tratamento modificado e cuidados de suporte.

O Dr. Cary Adams, CEO da UICC, disse: "A COVID-19 impactou o controle do câncer em todo o mundo e a resposta da comunidade do câncer tem sido extraordinária e até mesmo heroica. Este ano, mais do que nunca, é importante celebrarmos as conquistas da comunidade no Dia Mundial do Câncer. Em 2021, todos nós temos o objetivo de redirecionar nossos esforços coletivos para os desafios de longo prazo que o câncer impõe a todos os países do mundo. Devemos fazer mais prevenção, diagnosticar com maior antecedência e garantir que todos os pacientes de câncer tenham acesso ao tratamento de qualidade necessário."

Saiba mais sobre a campanha da NCCN para "envolver-se" na NCCN.org/WCD. Saiba mais sobre as iniciativas da NCCN sobre a pandemia da COVID-19 acessando NCCN.org/covid-19. As informações sobre o trabalho da NCCN para melhorar o tratamento do câncer em todo o mundo podem ser encontradas acessando NCCN.org/global. Participe da conversa on-line com a hashtag #NCCNGlobal.

Sobre a Rede Nacional Abrangente de Câncer 
A National Comprehensive Cancer Network® (NCCN®) é uma aliança sem fins lucrativos dos principais centros de câncer dedicados ao atendimento, pesquisa e educação de pacientes. A NCCN se empenha a melhorar e oferecer qualidade, eficácia, eficiência e acesso ao tratamento do câncer e oferecer melhor qualidade de vida para os pacientes. Acesse NCCN.org para obter mais informações sobre as diretrizes de prática clínica da NCCN em Oncologia (Diretrizes da NCCN®) e outras iniciativas. Siga a NCCN no Facebook @NCCNorg, Instagram @NCCNorg e no Twitter @NCCN.

Contato para a imprensa: 
Rachel Darwin 
267-622-6624 
[email protected]  

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

FONTE National Comprehensive Cancer Network

Related Links

www.nccn.org

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

New JNCCN Study Confirms it's 'Never Too Late' to See Survival Benefits from Quitting Smoking--Even With Late-Stage Cancer

New JNCCN Study Confirms it's 'Never Too Late' to See Survival Benefits from Quitting Smoking--Even With Late-Stage Cancer

New research published online in JNCCN—Journal of the National Comprehensive Cancer Network finds that people with cancer who quit smoking had a much ...

NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month

NCCN Guidelines Navigator for Breast Cancer Genetic Testing and Treatment Debuts During Breast Cancer Awareness Month

Today, the National Comprehensive Cancer Network® (NCCN®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Non-Alcoholic Beverages

Non-Alcoholic Beverages

Infection Control

Infection Control

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.